Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PepsiCo, Inc. (PEP) vs UnitedHealth Group Inc (UNH) Price & Performance

PepsiCo, Inc.Trade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

PepsiCo, Inc. vs UnitedHealth Group Inc — how do they compare? PepsiCo, Inc. trades at $135.65 (market cap $184.26B), while UnitedHealth Group Inc trades at $431.4 (market cap $396.27B). The key difference: UnitedHealth Group Inc is far larger — about 2.2× PepsiCo, Inc.'s market cap, and PepsiCo, Inc. pays the higher dividend (4.39%). Which is the better fit depends on your goals.

PEPUNH
Market Cap
$184.26B$396.27B
Sector
Consumer StaplesHealth
52-Week High
$170.44$436.35
52-Week Low
$134.98$237.77
Enterprise Value
$226.76B$442.96B
Dividend Yield
4.39%2.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PepsiCo, Inc.

PepsiCo (PEP) trades at $134.98, down 0.35% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $93.93B in 2025 with a net income margin of 10.78%, and it has beaten EPS estimates in the last three quarters. Recent news highlights price cuts on snacks like Doritos after consumer pushback and the termination of a music festival sponsorship.

The outlook is mixed: analyst consensus is a buy with a $158.79 price target, but near-term risks include competitive pressures and execution of the North American turnaround. Earnings growth and margin expansion from cost initiatives remain key catalysts for upside, though high valuation ratios and debt levels warrant caution.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $431.31, up 2.32% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations by 29%, and maintains robust cash flow from operations of $19.70 billion in 2025. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.

The outlook remains positive with an 82.69% analyst buy rating and a consensus price target of $476.50, implying 10.5% upside. Key risks include regulatory scrutiny, as seen in Massachusetts' $100 million Medicaid fraud lawsuit filed May 29, 2026, and margin pressure from rising medical costs. Long-term growth is supported by aging demographics and digital health investments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About PepsiCo, Inc.

PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.

Read more on PEP

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH